Headquartered in Shenzhen, China, Edge Medical is a global leader in surgical robotics innovation. Backed by renowned investors such as Sequoia Capital, Temasek Holdings, and Obimed, we are driven by the mission to "Advancing Surgery, Elevating Care," delivering high-quality robotic solutions to healthcare institutions worldwide.
Edge Medical® has a interdisciplinary R&D and manufacturing team of nearly 1,000 members. With over a decade of technological accumulation and refinement, our core surgical robotic systems are world-leading. Our company has established a robust and complete product portfolio, including multi-port laparoscopic surgical robots, single-port laparoscopic surgical robots, and bronchoscopic surgical robots.
Edge Medical® is the world’s second company to master multi-port, single-port, and bronchoscopic robotic technologies. In 2024, we conducted a groundbreaking transcontinental tele-surgery spanning from Rome and Bordeaux in Europe to Beijing, China, setting a new milestone in the history of human surgery.
With employees and partners spanning over 60 countries, Edge Medical aims to advance surgical practices through technological innovation, accelerate the global adoption of robotic surgery, and improve patient outcomes worldwide.